Are you Dr. Balmanoukian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 78 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-7911
Summary
- Dr. Ani Balmanoukian, MD is an oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and California. She is affiliated with Providence Saint John's Health Center and Cedars-Sinai Medical Center.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
- Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
- New York Medical CollegeClass of 2005
Certifications & Licensure
- CA State Medical License 2011 - 2026
- MD State Medical License 2008 - 2012
Clinical Trials
- INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors Start of enrollment: 2018 Aug 17
Publications & Presentations
PubMed
- 2628 citationsAtezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-a...Jonathan E. Rosenberg, Jean H. Hoffman-Censits, Thomas Powles, Michiel S. van der Heijden, Arjun Vasant Balar
Lancet. 2016-05-07 - 458 citationsAvelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.Andrea B. Apolo, Jeffrey R. Infante, Ani Sarkis Balmanoukian, Manish R. Patel, Ding Wang
Journal of Clinical Oncology. 2017-04-04 - 3406 citationsPembrolizumab for the treatment of non-small cell lung cancerEdward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian
Expert Opinion on Biological Therapy. 2015-05-20
Press Mentions
- Lung Cancer: Reasons for OptimismNovember 4th, 2024
- Presents State of Science SummitFebruary 21st, 2018
- ABMDR’s First Cancer Awareness Symposium Received with EnthusiasmSeptember 30th, 2016
- Join now to see all